Arginase-1 Liver Cancer Test | Lahalak Platform
An advanced laboratory test to detect Arginase-1 protein, a precise marker for diagnosing primary liver cancer and differentiating it from secondary tumors to ensure an effective treatment plan.
Scientific name: Immunohistochemistry: Arginase-1
A qualitative immunohistochemical (IHC) assay using a monoclonal antibody against arginase-1. It aims to detect strong cytoplasmic and sometimes nuclear expression of this enzyme, which is highly and specifically expressed in both normal and cancerous hepatocytes, making it an excellent marker for confirming the hepatic origin of cells.
Service type
Immunohistochemistry (IHC) Test
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- Detailed analysis to diagnose Arginase-1 protein expression in liver tumor tissue
- Consult a specialist to interpret the results.
- Personal support services from Lahalak
Medical Service Information
Conditions & Notices
- Prerequisite: Availability of FFPE tissue slides from a liver biopsy containing both tumor tissue and adjacent normal liver tissue (as an internal reference).
- This test is often requested as part of a diagnostic panel for HCC, which may include: Arginase-1 or HepPar-1, Glypican-3, and metastasis markers (CK7, CK20, CDX2 as suspected).
- The examination must be preceded by a preliminary histological diagnosis (H&E) of the liver lesion.
- Delivery time: 5-7 business days.
Medical services you might also like
